Skip to main content
. 2016 Mar 7;7(15):20597–20611. doi: 10.18632/oncotarget.7972

Table 1. Correction p-MEK1/SIRT1 expression and clinic-pathologic parameters of 87 hepatocellular carcinoma patients.

Variable Total p-MEK1/SIRT1 (High) p-MEK1/SIRT1 (Low) p-value
Age (years)
≤ 50 59 30 29 0.541
> 50 24 14 10
Gender
Female 15 10 5 0.331
Male 72 38 34
Tumor stage
I 5 1 4 < 0.001***
II 39 16 23
III 43 31 12
Tumor size (cm)
< 5 23 7 16 0.012*
≥ 5 59 36 23
Serum AFP level (ng/ml)
≤ 20 18 9 9 0.721
> 20 62 34 28
Tumor recurrence
45 22 23 0.227
+ 42 26 16
Necrosis
+ 38 17 21 0.395
++ 26 19 7
+++ 23 12 11
Capsular invasion
27 10 17 0.048*
+ 35 22 13
++ 25 16 9
Vascular invasion
25 7 18 < 0.001***
+ 62 41 21
Interstitial hyperplasia of tumor
+ 22 13 9 0.969
++ 36 18 18
+++ 29 17 12

Note: (1) *p < 0.05 ***p < 0.001 was considered statistically significant. (2) P-values were calculated with the Person chi-square test. (3) Total number < 87 due to missing data.